RxDoctor Payments Data

Nathan Wiens, PA

Physician Assistant · Spokane, WANPI 1316188220

Payments from drug & device makers

$2,940in general payments, 2019–2025

Across 154 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$614
  • AbbVie$450
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$437
  • Ipsen Biopharmaceuticals, Inc$400
  • Boston Scientific$239
  • Nevro Corp.$222
  • plus $577 from 13 others

What the payments were for

  • Food & beverage$2,940100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,940 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$94,015
Medicare patients
176
Services billed
987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl146$86,500
Xtampza ErOxycodone Myristate115$84,194
RelistorMethylnaltrexone Bromide12$25,458
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen795$23,051
BelbucaBuprenorphine Hcl21$16,611
Morphine Sulfate ErMorphine Sulfate400$12,448
Oxycodone Hcl690$11,920
LyricaPregabalin12$10,468
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen254$9,524
Buprenorphine55$8,891
Fentanyl87$8,052
MovantikNaloxegol Oxalate13$5,942
Tizanidine Hcl182$4,081
Hydromorphone ErHydromorphone Hcl14$3,814
Methadone Hcl82$3,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$614$100,805136 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$437$25,45812 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl, Morphine Sulfate$17$14,700219 claims
PfizerLyrica$120$10,46812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →